Embecta Corp. Declares Quarterly Cash Dividend of $0.15 Per Share

Embecta Corp. declared a quarterly cash dividend of $0.15, payable December 18, 2024, to eligible shareholders.

Quiver AI Summary

Embecta Corp. has announced a quarterly cash dividend of $0.15 per share for its common stock, with payment scheduled for December 18, 2024, to shareholders on record as of December 6, 2024. The company, which has a century-long history in diabetes care, aims to enhance the lives of people with diabetes through innovative solutions and partnerships, supported by a global team of over 2,000 employees. For further details, interested parties can visit their website or follow their social media channels.

Potential Positives

The declaration of a quarterly cash dividend demonstrates the company's financial stability and commitment to returning value to its shareholders.
The dividend payment is a positive signal to investors, indicating the company's confidence in its ongoing profitability and cash flow.
Paying dividends can attract new investors and maintain interest from current shareholders, potentially stabilizing the stock price.

Potential Negatives

The declaration of a relatively low quarterly dividend of $0.15 per share may signal to investors that the company is not in a strong financial position to provide higher returns.
The need for a dividend payment could suggest that the company is prioritizing short-term payouts over long-term growth investments.
The timing of the dividend payment, shortly before the end of the calendar year, may indicate a desire to manage investor expectations amidst potential financial uncertainties.

FAQ

What is the dividend amount declared by Embecta Corp.?

The Board of Directors of Embecta Corp. has declared a quarterly cash dividend of $0.15 per share.

When will Embecta's dividend be paid?

The dividend is payable on December 18, 2024, to stockholders of record as of December 6, 2024.

Who is eligible to receive the dividend from Embecta?

Stockholders of record at the close of business on December 6, 2024, are eligible to receive the dividend.

What does Embecta Corp. specialize in?

Embecta Corp. is a global diabetes care company focusing on insulin delivery solutions for people with diabetes.

How can I learn more about Embecta Corp.?

More information about Embecta can be found on their website at embecta.com and through their social media channels.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$EMBC Hedge Fund Activity

We have seen 105 institutional investors add shares of $EMBC stock to their portfolio, and 212 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

RUBRIC CAPITAL MANAGEMENT LP added 1,085,529 shares (+inf%) to their portfolio in Q3 2024
MILLENNIUM MANAGEMENT LLC removed 1,037,109 shares (-30.1%) from their portfolio in Q3 2024
SIO CAPITAL MANAGEMENT, LLC removed 585,418 shares (-100.0%) from their portfolio in Q2 2024
JACOBS LEVY EQUITY MANAGEMENT, INC removed 438,924 shares (-62.7%) from their portfolio in Q3 2024
JEFFERIES FINANCIAL GROUP INC. added 358,000 shares (+inf%) to their portfolio in Q3 2024
AQR CAPITAL MANAGEMENT LLC removed 345,263 shares (-56.2%) from their portfolio in Q3 2024
BLACKROCK, INC. added 322,762 shares (+3.5%) to their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release

PARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on December 18, 2024 to stockholders of record at the close of business on December 6, 2024.

About embecta
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn , Facebook , and Instagram .

Contacts:

Media Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations	Investors Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR